Original Research Article
Year: 2022 | Month: December | Volume: 12 | Issue: 12 | Pages: 208-213
DOI: https://doi.org/10.52403/ijhsr.20221231
Acceptability of Two Oral Unani Dosage Forms in Pediatric Patients
Amjad W. Yousuf1, Aasiy ul Erum2, Afroza Rahman3
1Department of Ilmul Atfaal, Government Unani Medical College, Kashmir
2Department of Ilmul Advia, Government Unani Medical College, Kashmir
3Department of Tahfuzi Wa Samaji Tibb, Government Unani Medical College, Kashmir
Corresponding Author: Dr Afroza Rahman
ABSTRACT
Objective: Unani compound formulations in various dosage forms are frequently prescribed to pediatric population for treatment and management of various diseases. The information about the acceptability of these formulations in pediatric population remains scarce even though this multi-faceted concept is a major factor to determine patient compliance and the limited understanding hinders the development of acceptable, age-appropriate medicines. Present study was designed to record the acceptability of oral Unani dosage forms in pediatric patients treated in an Unani hospital in J&K India.
Methods: An observational cross-sectional study was carried out in patients aged 3 years to 10 years attending taking Jawarish (semi-solid) and Sharbat (Syrup) two Oral Unani formulations. VAS Acceptability Score Test tool was used to record the acceptability scores and parental preferences.
Results: 387 patients were recruited out of which only 157 completed the study. Out of 157 evaluations 47.77 % were for Jawarish (semi-solid) and 52.22 evaluations were for Sharbat (Syrup). Irrespective of therapeutic use and age, the Sharbat (Syrup) weas ’positively accepted’ in both age groups and genders. Parental preference was also significantly higher for Sharbat (Syrup) as compared to Jawarish (semi-solid).
Conclusion: We conclude that Sharbat (Syrup) is an acceptable dose form in Unani System of medicine, Development of novel dosage forms which are acceptable and preferred in pediatric patients for formulations like Jawarish will increase the therapeutic options to treat pediatric patients
Key words: Pediatric; Dosage form; Unani; Jawarish; Sharbat.